These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9844472)
41. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa. Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302 [TBL] [Abstract][Full Text] [Related]
42. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207 [TBL] [Abstract][Full Text] [Related]
43. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827 [TBL] [Abstract][Full Text] [Related]
44. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe]. Cavallo JD; Mérens A Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568 [TBL] [Abstract][Full Text] [Related]
45. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa. Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356 [TBL] [Abstract][Full Text] [Related]
46. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan. Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840 [TBL] [Abstract][Full Text] [Related]
47. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria]. Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417 [No Abstract] [Full Text] [Related]
49. Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa. Tam VH; Schilling AN; Melnick DA; Coyle EA Diagn Microbiol Infect Dis; 2005 Jun; 52(2):145-51. PubMed ID: 15964503 [TBL] [Abstract][Full Text] [Related]
50. Antibiotic resistance in Pseudomonas aeruginosa related to quinolone formulary changes: an interrupted time series analysis. Church EC; Mauldin PD; Bosso JA Infect Control Hosp Epidemiol; 2011 Apr; 32(4):400-2. PubMed ID: 21460495 [No Abstract] [Full Text] [Related]
51. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Wolter DJ; Smith-Moland E; Goering RV; Hanson ND; Lister PD Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277 [TBL] [Abstract][Full Text] [Related]
52. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa]. Torres A; Vega J; Aguirre M; Alés JM Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752 [No Abstract] [Full Text] [Related]
53. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. Gad GF; El-Domany RA; Zaki S; Ashour HM J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321 [TBL] [Abstract][Full Text] [Related]